CellFE applications

A critical question in determining the mechanism of action of cell therapies is “do the cells go where you want them to?” Clinical cell tracking can answer this question and CellFE technology is uniquely suited for delivering of FDA-approved contrast agents to cells.

Absence of a means for affordable and effective cell engineering hinders the commercialization of these advanced treatments. CellFE’s technology can get life-saving therapies to the patient at lower cost, with shorter manufacturing time, and higher retention of inherent functionality.

Simple transfection solutions that are scalable and consistent from R&D through production are desired to eliminate variability along the development pipeline and reduce the cost of biomanufacturing. CellFE’s easy to use and scalable technology efficiently transfects any cell line without viruses or surfactants, using off-the-shelf buffers.